Melatonin: A Deep Dive into the Science Beyond Sleep

Today, I want to talk about a molecule that is often confined to the category of a simple sleep aid, yet its benefits are so profound and far-reaching that every single patient and provider should understand its potential: Melatonin.

This is a particularly important topic given the news release from the American Heart Association (AHA) last week suggesting that melatonin may have negative health effects. The truth is that melatonin has many significant health benefits and the study that the AHA posted last week is a Grade D study looking at a prescription database, meaning that the study is only useful for hypothesis generation at best. Association DOES NOT mean causation, something that medical societies like the AHA, Menopause Society, etc. seem to struggle significantly with.

Melatonin, chemically known as N-acetyl-5-methoxytryptamine, is a neuroendocrine hormone primarily produced by the pineal gland, though it is also synthesized in extrapineal sources like the bone marrow, eyes, GI tract, and lymphocytes. Its secretion is tightly regulated by light information received by photoreceptor cells in the retina and typically peaks between 2 AM and 4 AM.

While its traditional function is to synchronize circadian and seasonal rhythms and modulate sleep patterns, dismissing melatonin merely as a sleep hormone overlooks its extensive role as a powerful pleiotropic molecule in human physiology.

Melatonin: The Research Deep Dive

The compelling evidence supporting the use of melatonin extends far beyond simply getting eight hours of rest.

The Master Antioxidant and Anti-inflammatory Agent

Melatonin is arguably one of the most potent antioxidants and free radical scavengers known. It possesses anti-inflammatory properties and acts as an immune buffer.

• Antioxidant Power: Melatonin's antioxidant role allows it to scavenge the most reactive and destructive free radical, the hydroxyl radical, and generally reduce damage in all cells and organs. It also significantly increases glutathione levels, the body's master antioxidant.

• Inflammation Control: Melatonin exhibits anti-inflammatory effects by suppressing inflammatory pathways and dampening the exacerbated production of pro-inflammatory mediators. For instance, it significantly decreases inflammatory markers like C-reactive protein and Interleukin-6 (IL-6). Melatonin can also inhibit NLRP-3 inflammasomes, proteins linked to inflammation in the lungs, demonstrating its potential to reduce tissue destruction during inflammatory immune reactions.

Metabolic Regulation and Glycemic Control

The connection between sleep and metabolic health is undeniable, but the molecule linking them is melatonin.

• Insulin Sensitivity: Large-scale meta-analyses have demonstrated a promising effect of melatonin supplementation on glycemic control. Pooled findings indicate that melatonin supplementation significantly reduces fasting glucose and increases insulin sensitivity. This is highly relevant for patients suffering from dysglycemia and insulin resistance.

• Lipid Profile: Melatonin also shows favorable effects on lipid panels, with studies indicating a significant decrease in triglycerides and total cholesterol at doses greater than 8 mg/day.

• Pancreatic Function: Melatonin has direct metabolic effects by suppressing insulin secretion at night, mediated by the MT1 and MT2 receptors located in the pancreas. This suppression allows beta cells to recover and heal while the body is fasting and resting. Low levels of melatonin metabolites are associated with increased insulin resistance and Type 2 Diabetes Mellitus (T2DM) risks.

Neuroprotection and Brain Detoxification

For those concerned about cognitive health and neurodegenerative disorders, melatonin is an essential protective molecule.

• The Glymphatic System: The brain’s ability to clear toxic proteins, such as beta-amyloid linked to Alzheimer’s disease (AD), is tied to deep sleep. The glymphatic system, the brain's detoxification mechanism, functions most effectively during deep sleep. Melatonin specifically increases stage three and stage four (deep) sleep, which is critical for clearing these toxic proteins. Melatonin appears effective and safe in improving sleep quality in AD patients and may serve as a protective molecule against cognitive dysfunction in T2DM patients who often have low melatonin levels.

• Mitochondrial Protection: Melatonin concentrates in neuronal mitochondria, where it stabilizes membrane potential and reduces apoptosis, which is particularly relevant in conditions like AD and traumatic brain injury (TBI).

Immune Enhancement and Anti-Cancer Potential

The literature on melatonin’s role in immune modulation and cancer is extensive.

• Anti-Cancer Effects: Melatonin has demonstrated anti-proliferative and anti-cancer activity in experimental models. For example, studies show that melatonin treatment dramatically reduces the number of prostate cancer cells and stops cell cycle progression. In postmenopausal women, lower levels of melatonin have been associated with a statistically significant higher risk of invasive breast cancer.

• Immune Function: Melatonin increases natural killer (NK) cells and T-helper production, including CD4+ cells, and stimulates the production of progenitor cells of granulocytes and macrophages.

Cardiovascular Protection

Melatonin is recognized for its cardioprotective activity in multiple animal and human studies.

• Hypertension and Heart Rate: Melatonin has shown benefits in reducing cardiac pathology and preventing heart muscle hypertrophy. It can reduce nocturnal blood pressure in hypertensive patients and serves as a potent protective agent against reperfusion injury after myocardial infarction.

Addressing Misconceptions and Clinical Strategy

Despite this impressive dossier of benefits, patients and many providers harbor misconceptions, particularly regarding long-term use and dosing.

Misconception 1: Taking Supplemental Melatonin Will Shut Down My Natural Production.

This is a frequently asked question, and the short answer is no, chronic suppression of endogenous production by supplementation is not well established, and generally, if you stop supplementation, your body reverts to its baseline production levels. Melatonin is a hormone, and if you were a poor producer before, you will likely return to being a poor producer, but the inherent ability to synthesize it is not stopped. Since the common over-the-counter doses (5-10 mg) are far higher than the natural endogenous production (0.5 to 1 mg), the acute supplementation merely provides a temporary surplus.

Misconception 2: High Doses Are Dangerous.

I hear this frequently from sleep doctors who suggest anything over three milligrams is too much. However, the literature is remarkably consistent on melatonin's safety profile: it is remarkably atoxic, and its safety is very high. Research has demonstrated administration of melatonin up to 1600 mg/day for periods up to 3.5 years with no adverse events reported in 26 studies reviewed.

My Clinical Strategy on Dosing:

• Individualized Titration: You must titrate the dose to effect. Start low, usually at 3 mg nightly for men, and 1 to 3 mg for women (who may benefit greatly from oral progesterone instead or in addition).

• The Goal: The aim is to find the dose that allows you to sleep deeply without feeling groggy or excessively sleepy the next morning.

• Higher Doses for Protection: For the anti-cancer, anti-inflammatory, and neuroprotective benefits discussed, doses often need to be much higher (e.g., anti-inflammation starts at 10 mg; anti-cancer doses can be 1,000 mg sustained-release).

• Formulation Matters: Use compounded, micronized, sustained-release (SR) formulations whenever possible, as they provide a half-life of about six to eight hours, which is superior to the two- to three-hour half-life of most over-the-counter products.

Melatonin: The Preferred Alternative

It is critical to remember that healthy sleep is a byproduct of overall good health, not a magic pill. Pharmaceuticals like Z-drugs (Ambien/zolpidem) or Trazodone are known to hijack the GABA system, leading to dependency and potentially raising the risk of diabetes and increasing insulin resistance. Furthermore, a recent study suggested that zolpidem reduces glymphatic flow in the brain.

Melatonin, often combined with oral micronized progesterone for women, offers a much safer and more physiological approach to optimizing sleep quality, especially the deep stage 3 and 4 sleep required for restoration, growth hormone release, and brain clearance.

In conclusion, melatonin is far more than a simple sleep aid. It is a critical hormone that acts as the body's night-shift supervisor, coordinating immune security patrols, managing metabolic repair, and cleaning up the brain. Given its tremendous safety profile and overwhelming evidence of benefit across metabolic, cardiovascular, neurological, and immune systems, it is an essential component of any comprehensive health optimization strategy.

- Luke Swift, DNP, APN-FPA, PMHNP-BC, ABHRT

References

- Cardinali, D. (2019). Melatonin: Clinical Perspectives in Neurodegeneration. Frontiers in Endocrinology, 10(480).

- Carrillo-Vico, A. et al. (2013). Melatonin: Buffering the immune system. International Journal of Molecular Sciences, 14(4), 8638-8683.

- Dominguez-Rodriguez A, et al. (2017). Usefulness of early treatment with melatonin to reduce infarct size in patients with ST-segment elevation myocardial infarction receiving percutaneous coronary intervention (from the melatonin adjunct in the acute myocardial infarction treated with angioplasty trial). The American Journal of Cardiology, 120(4), 522-526.

- Doosti-Irani, A. et al. (2018). The effects of melatonin supplementation on Glycemic control: A systematic review and meta-analysis of randomized controlled trials. Hormone and Metabolic Research, 50(11), 783-790.

- Foley, H. & Steel, A. (2019). Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Complementary Therapies in Medicine, 42, 65-81.

- Garaulet, M. et al. (2020). Melatonin Effects on Glucose Metabolism: Time To Unlock the Controversy. Trends in Endocrinology & Metabolism, 31(3), 192-204.

- Gögenur I, et al. (2014). Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurysm repair: a randomized, placebo-controlled, clinical trial. Journal of Pineal Research, 57(1), 10-15.

- Hauglund, N. et al. (2025). Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep. Cell, 188(3), 606-622.

- Hoseini, S. et al. (2021). Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: a randomized, double-blinded clinical trial. Clinical Cardiology, 44(9), 1263-1271.

- Kim, J., Lee, S., & Lee, J. (2021). Melatonin for the prevention of fetal injury associated with intrauterine inflammation. American Journal of Reproductive Immunology, 86(1).

- Lerner, A., Case, J., Takahashi, Y., Lee, T., & Mori, W. (1958). ISOLATION OF MELATONIN, THE PINEAL GLAND FACTOR THAT LIGHTENS MELANOCYTES. Journal of the American Chemical Society, 80(10), 2587–2587.

- Lissoni, P, et al. (2003). Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. Journal of Pineal Research, 35(1), 12-15.

- Man, G. et al. (2017). The regulations and role of circadian clock and melatonin in uterine receptivity and pregnancy - An immunological perspective. American Journal of Reproductive Immunology, 78(2).

- Manchester, L. et al. (2015). Melatonin: an ancient molecule that makes oxygen metabolically Tolerable. Journal of Pineal Research, 59(4), 403–419.

- Mohammadi-Sartang, M. et al. (2018). Effects of melatonin supplementation on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition, 37(6), 1943-1954.

- Schernhammer, E. et al. (2008). Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal Women. Journal of the National Cancer Institute, 100(12), 898-905.

- Suofu, Y. et al. (2017). Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proceedings of the National Academy of Sciences, 114(38).

- Tobeiha, M. et al. (2022). Evidence for the Benefits of Melatonin in Cardiovascular Disease. Frontiers in Cardiovascular Medicine, 9. doi:10.3389/fcvm.2022.888319.

- Wang, L., Wang, C., & Choi, W. (2022). Use of Melatonin in Cancer Treatment: Where Are We? International Journal of Molecular Sciences, 23(7), 3779. doi:10.3390/ijms23073779.

- Xie et al. (2017). A review of sleep disorders and melatonin. Neurological Research, 39(6), 559-565.

- Zisapel, N. (2018). New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. British Journal of Pharmacology, 175(16), 3190–3199.